The above studies suggest that Lp(a) and OxPL may promote CAVD by directly inducing the expression of related inflammatory genes, IL-1, and the NF-κB—IL-6 pathway. The gene discussed is IL6; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.